Editor | Curator

Advertisment

How Incannex is positioning to be the ‘next GW Pharma’, with CEO Joel Latham (Stockhead)

Incannex provides investors the best of breed for medicinal cannabis and psychedelic therapy development – and they’re looking at an excursion to the USA For Incannex Healthcare (ASX:IHL) CEO...

2021 Psychedelic Investor Guide

OPEN GUIDE Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...

Side Stories

Headlines Worth Scrolling Through (Bookmark this) Some of our favorite educational stories on the effects of Psychedelics. AUGUST 12,...

Scientists Studying Psychoactive Drugs Accidentally Proved the Self is an Illusion (Quartz)

A Great Explanation of How Psilocybin Works - and Easy on the Scientific Terms. Ryan Christodoulou Philosophers and mystics have long contemplated the disconcerting...

Editor | Curator

Advertisment